Alembic Pharma Gets US FDA Inspection Report for Gujarat API Units

Alembic Pharmaceuticals Ltd. on Saturday said it has received an establishment inspection report from the US Food and Drug Administration for its active pharmaceutical ingredient (API) I and API II facilities at Panelav in Gujarat.

The inspection was conducted between May 26 and May 31, the company said in an exchange filing.